Clinicohematological correlation and chromosomal breakage analysis in suspected Fanconi anemia patients of India

Abstract

Introduction: The management of patients with aplastic anemia, to an extent, depends on the etiology i.e., inherited or acquired. The classical Chromosomal breakage study involves detection of chromosomal breakage or aberrations (breaks, gaps, rearrangements, radials, exchanges, endoreduplications) in peripheral blood cells after culture with a T-cell mitogen and a DNA clastogenic (cross-linking) agent, such as diepoxybutane (DEB) or mitomycin C (MMC). The testing needs to be performed in laboratory with appropriate expertise in Fanconi Anemia testing. The present study was undertaken to find out the frequency of inherited aplastic anemia in North India. Materials and Methods: This study was carried out at the Department of Molecular Biology and Transplant Immunology, Indraprastha Apollo hospital, New Delhi. The study includes retrospective analysis of 528 aplastic anemia patients whose samples were tested at our department for Chromosomal breakage study during the period 2007 to 2011. Respective age and sex matched healthy controls were also processed for chromosomal breakage study. Patient′s habitat, clinical symptoms, differential blood count and history of drug exposure were documented for all patients referred to us, whereever available. Relative risk was estimated by odds ratio (OR) with 95% confidence interval (CI) in matched cases and controls. Conclusion: A significant increase in chromosomal breakages was seen in 13.1% patients. The survival data documented for 100 patients suggested 60% mortality.

Keywords

Aplastic anemia - chromosomal anomalies - chromosomal breakage studies - Fanconis anemia - mitomycin-C

Publication History

Article published online:
19 July 2021

• References

• 1 Cirkoviæ S, Šæekiæ MG, Vujiæ D, Miæiæ D. Cytogenetic diepoxybutane sensitivity in Serbian children with Fanconi anemia. Arch Biol Sci Belgrad 2006;58:215-9.
• 2 Pinto FO, Leblanc T, Chamousset D, Le Roux G, Brethon B, Cassinat B, et al. Diagnosis of Fanconi anemia in patients with bone marrow failure. Haematologica 2009;94:487-95.
• 3 Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res 2009;668:4-10.
• 4 Talwar R, Choudhry VP, Kucheria K. Differentiation of Fanconi anemia from idiopathic aplastic anemia by induced chromosomal breakage study using mitomycin-C (MMC). Indian Pediatr 2004;41:473-7.
• 5 Jain D, Raina V, Fauzdar A, Mishra M, Tyagi N, Mahajan A, et al. Chromosomal breakage study in aplastic anemia patients in India. Asian J Med Sci 2010;2:227-32.
• 6 Varma N, Varma S, Marwaha RK, Malhotra P, Bansal D, Malik K, et al. Multiple constitutional aetiological factors in bone marrow failure syndrome (BMFS) patients from north India. Indian J Med Res 2006;124:51-6.
• 7 Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: An International fanconi Anemia Registry study. Blood 1994;84:1650-5.
• 8 Fohlmeister I, Fischer R, Mödder B, Rister M, Schaefer HE. Aplastic anaemia and the hypocellular myelodysplastic syndrome: Histomorphological, diagnostic, and prognostic features. J Clin Pathol 1985;38:1218-24.
• 9 Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993;21:731-3.
• 10 Esmer C, Sánchez S, Ramos S, Molina B, Frias S, Carnevale A. DEB test for Fanconi anemia detection in patients with atypical phenotypes. Am J Med Genet A 2004;124A:35-9.
• 11 Zen PR, Moraes FN, Rosa RF, Graziadio C, Paskulin GA. Clinical characteristics of patients with Fanconi anemia. São Paulo. Rev Paul Pediatr 2011;29:1-5.